A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors

NCT04587479 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors, Adult

Interventions

DRUG: JAB-8263

Sponsor

Jacobio Pharmaceuticals Co., Ltd.